Insider Transactions Reported by 23 Insiders of 4D Molecular Therapeutics, Inc.

Symbol
FDMT on Nasdaq
Location
Emeryville, CA

Insiders trading volume in the past year

4D Molecular Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
VIKING GLOBAL INVESTORS LP 10%+ Owner $78,195,176 04 Jan 2024
RA CAPITAL MANAGEMENT, L.P. 10%+ Owner $74,517,236 09 Dec 2024
David Kirn Chief Executive Officer, Director $23,817,068 06 Mar 2025
DAVID SCHAFFER Director $16,589,476 20 Oct 2021
BVF PARTNERS L P/IL Other* $1,435,587 08 Nov 2024
Ashoo Gupta VP, Finance and Controller $402,396 -$3,377 -0.83% 20 Dec 2025
August J. Moretti Chief Financial Officer $203,315 15 May 2023
CHARLES THEUER Director $47,519 12 Dec 2025
Scott Bizily Chief Legal Officer $39,174 -$127,236 -76% 16 Dec 2025
Carolyne Zimmermann Chief Business Officer 01 Feb 2022
JOHN F. MILLIGAN Director 17 Jun 2025
Christopher Paul Simms Chief Commercial Officer 09 Dec 2025
Shawn Tomasello Director 17 Jun 2025
Nancy Miller-Rich Director 17 Jun 2025
Kristian Humer Chief Financial Officer 09 Dec 2025
Uneek Mehra Chief Financial & Business Officer 06 Mar 2025
ROBERT FISHMAN Chief Medical Officer 01 Sep 2022
Robert Young Kim Chief Medical Officer 06 Mar 2025
GLENN SBLENDORIO Director 05 Jan 2026
SUSANNAH GRAY Director 17 Jun 2025
Jacob Chacko Director 17 Jun 2025
Fariborz Kamal President & COO 06 Mar 2025
Noriyuki Kasahara Director 23 May 2023

Recent Insider Transactions by Companies or Individuals for 4D Molecular Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.